ロード中...
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
Denosumab (AMG 162) is an investigational fully human monoclonal antibody with a high affinity and specificity for receptor activator of nuclear factor-κB ligand (RANKL), a cytokine member of the tumor necrosis factor family. RANKL, the principal mediator of osteoclastic bone resorption, plays a maj...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727882/ https://ncbi.nlm.nih.gov/pubmed/19707445 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|